Skip to content

Clinical study of unani compound formulation in treatment of kidney stones.

Clinical study of Hasah-al-kuliya(Nephrolithiasis) and Evaluation of Therapeutic efficacy of Unani Compound Formulation in its Management.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039603
Enrollment
40
Registered
2022-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: Joshanda(Decoction) of Haliyun(Asparagus officinalis Linn)and Tukhm-e-kharpaza(seeds of Cucumis melow): 6gms of Haliyun(Asparagus officinalis Linn)and 7gms of Tukhm-e-kharpaza(seeds of

Sponsors

Central Council of Unani Medicine New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically/ radiologically diagnosed patients of Hasah-e-Kulya (Nephrolithiasis) from size 5 to 10mm. Patients irrespective of gender. Patients between 18 to 60 years of age. Patients who are agreed to sign the informed consent form and follow the protocol.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women Patients below the age of 18 years and above the age of 60 years. Diabetes Mellitus. Hydronephrosis grade II and above Poorly controlled Hypertension. Significant Liver and Renal dysfunction. Cardiovascular diseases. Unwillingness or inability to sign consent form. A medical condition that in the investigatorâ??s opinion would interfere the treatment, safety or adherence to protocol.

Design outcomes

Primary

MeasureTime frame
relief in signs and symptoms of nephrolithiasisTimepoint: 45 days

Secondary

MeasureTime frame
Haematological, radiological and biochemical assesmentTimepoint: 45 days

Countries

India

Contacts

Public ContactDr Shameem Ahmed Rather

Regional Research Institute of Unani Medicine(RRIUM) Srinagar

shameem.rather.sr@gmail.com7889584083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026